SS

Suman Sharma

Active Director Director DIN 00981732
DIN 00981732 First appointment Dec 2006 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Dec 2006
Shareholding value •••• Premium profile

About Suman Sharma

Data last updated:

Suman Sharma is a Director at Shiny Pharmaceuticals Private Limited (since 2006). The company operates in Pharma. Shiny Pharmaceuticals Private Limited reported revenue of ₹4.22 Cr (FY 2024).

DIN 00981732
Primary Designation Director
Industry Pharma
First Appointment 22 Dec 2006
Oldest Company Age 19 yrs
Largest company Shiny Pharmaceuticals Private Limited · ₹4.22 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director22 Dec 20062006₹4.22 Cr (FY 2024)Active

Board colleagues of Suman Sharma

Directorship timeline

Open interactive timeline →
Shiny Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Suman Sharma

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Suman Sharma

Suman Sharma currently holds 1 directorship: Shiny Pharmaceuticals Private Limited (Director, since 22 Dec 2006, revenue ₹4.22 Cr (FY 2024)).

Suman Sharma was first appointed on 22 Dec 2006 as Director at Shiny Pharmaceuticals Private Limited.

The current boards of Suman Sharma's companies include Pawan Sharma (Shiny Pharmaceuticals Private Limited), Ragini Gupta (Shiny Pharmaceuticals Private Limited), Vishal Bhusan Gupta (Shiny Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available